Related Experiment Video
Updated: May 30, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in
Leike Xie1, Chi Vo-Ransdell, Britain Abel
1Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA.
Abstract:
Using a combination of wild-type (WT) and caveolin-2 (Cav-2) knockout along with retroviral reexpression approaches, we provide the evidence for the negative role of Cav-2 in regulating anti-proliferative function and signaling of transforming growth factor β (TGF-β) in endothelial cells (ECs). Although, TGF-β had a modest inhibitory effect on WT ECs, it profoundly inhibited proliferation of Cav-2 knockout ECs. To confirm the specificity of the observed difference in response to TGF-β, we have stably reexpressed Cav-2 in Cav-2 knockout ECs using a retroviral approach. Similar to WT ECs, the anti-proliferative effect of TGF-β was dramatically reduced in the Cav-2 reexpressing ECs. The reduced anti-proliferative effect of TGF-β in Cav-2-positive cells was evidenced by three independent proliferation assays: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell count, and bromodeoxyuridine incorporation and correlated with a loss of TGF-β-mediated upregulation of cell cycle inhibitor p27 and subsequent reduction of the levels of hyperphosphorylated (inactive) form of the retinoblastoma protein in Cav-2 reexpressing ECs. Mechanistically, Cav-2 inhibits anti-proliferative action of TGF-β by suppressing Alk5-Smad2/3 pathway manifested by reduced magnitude and length of TGF-β-induced Smad2/3 phosphorylation as well as activation of activin receptor-like kinase-5 (Alk5)-Smad2/3 target genes plasminogen activator inhibitor-1 and collagen type I in Cav-2-positive ECs. Expression of Cav-2 does not appear to significantly change targeting of TGF-β receptors I and Smad2/3 to caveolar and lipid raft microdomains as determined by sucrose fractionation gradient. Overall, the negative regulation of TGF-β signaling and function by Cav-2 is independent of Cav-1 expression levels and is not because of changing targeting of Cav-1 protein to plasma membrane lipid raft/caveolar domains.
Insights
Caveolin-2 (Cav-2) negatively regulates the anti-proliferative effects of transforming growth factor-beta (TGF-β) in endothelial cells. Loss of Cav-2 enhances TGF-β signaling, while its reexpression diminishes this response.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator of cell proliferation and signaling.
- Caveolins, including caveolin-2 (Cav-2), are proteins involved in cellular signaling and membrane dynamics.
- The precise role of Cav-2 in TGF-β signaling pathways, particularly in endothelial cells, requires further elucidation.
Purpose of the Study:
- To investigate the role of caveolin-2 (Cav-2) in regulating the anti-proliferative function of transforming growth factor-beta (TGF-β) in endothelial cells (ECs).
- To elucidate the molecular mechanisms by which Cav-2 influences TGF-β signaling.
- To determine if Cav-2 affects the localization of TGF-β pathway components.
Main Methods:
- Utilized wild-type (WT) and Cav-2 knockout endothelial cells (ECs).
- Employed retroviral reexpression of Cav-2 in knockout ECs.
- Assessed cell proliferation using MTT assays, cell counting, and bromodeoxyuridine incorporation.
- Analyzed TGF-β signaling components, including p27, retinoblastoma protein, Alk5, and Smad2/3 phosphorylation.
- Investigated protein localization in lipid raft/caveolar microdomains via sucrose fractionation gradients.
Main Results:
- Cav-2 knockout ECs exhibited profoundly inhibited proliferation upon TGF-β treatment compared to WT ECs.
- Reexpression of Cav-2 in knockout ECs restored the modest anti-proliferative effect of TGF-β.
- Cav-2 suppressed TGF-β-induced upregulation of p27 and hyperphosphorylated retinoblastoma protein.
- Cav-2 inhibited the Alk5-Smad2/3 pathway, reducing Smad2/3 phosphorylation and target gene activation.
- Cav-2 expression did not significantly alter the targeting of TGF-β receptors or Smad2/3 to caveolae/lipid rafts.
Conclusions:
- Caveolin-2 plays a negative regulatory role in the anti-proliferative function and signaling of TGF-β in endothelial cells.
- Cav-2 inhibits TGF-β's anti-proliferative action by suppressing the Alk5-Smad2/3 pathway.
- This regulation by Cav-2 is independent of Cav-1 expression and does not involve altered localization of key signaling molecules to lipid rafts.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway